4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-24-000195
COFO and Secretary sold 8,353 shares at an average $23.99 ($200,401)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X05/wk-form4_1724357674.xml…